Cipla Ltd

  • BSE Code : 500087
  • NSE Symbol : CIPLA
  • ISIN : INE059A01026
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,475.75 -3.95(-0.27%)

Open Price ()

1,489.00

Prev. Close ()

1,479.70

Volume (No’s)

1,413,123

Market Cap ()

119,183.64

Low Price ()

1,468.65

High Price ()

1,502.00

 

Board Meetings

Start Date End Date Purpose
06-Jan-2025 28-Jan-2025 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 31st December 2024. Unaudited Financial Results (standalone and consolidated) for the quarter and nine months ended 31st December, 2024. Outcome of Board Meeting dated 28th January, 2025 (As Per BSE Announcement dated on 28.01.2025)
01-Oct-2024 29-Oct-2024 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2024. Unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2024 Outcome of Board meeting dated 29th October 2024 (As Per BSE Announcement Dated on: 29/10/2024)
03-Sep-2024 03-Sep-2024 Outcome of Board meeting held on 3rd September 2024 Change in Directors of the Company Corrigendum - Outcome of Board meeting held on 3rd September 2024 (As Per BSE Announcement Dated on 04.09.2024)
04-Jul-2024 26-Jul-2024 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2024. Outcome of the Board Meeting held on 26th July 2024 (As per BSE Announcement Dated on 26/07/2024)
05-Apr-2024 10-May-2024 CIPLA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve 1. Consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2024. 2. Recommend final dividend for the year ended 31st March 2024 if any. In terms of the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company is closed from Monday 1st April 2024 till Sunday 12th May 2024 (both days inclusive) for the purpose of financial results. Outcome of board meeting held on 10th May 2024 Appointment of Cost Auditor for FY 2024-25 (As Per BSE Announcement Dated on 10/05/2024)

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew